
Global Pharmaceutical Logistics Market – Industry Trends and Forecast to 2031
Report ID: MS-118 | Automotive and Transport | Last updated: Nov, 2024 | Formats*:

Pharmaceutical Logistics Report Highlights
Report Metrics | Details |
---|---|
Forecast period | 2019-2031 |
Base Year Of Estimation | 2023 |
Growth Rate | CAGR of 9.5% |
By Product Type | Cold Chain Logistics, Non-cold Chain Logistics |
Key Market Players |
|
By Region |
Pharmaceutical Logistics Market Trends
The pharmaceutical logistics market is heavily undergoing a shift toward more digitalisation and automation because of the advancement of technology and the need for greater efficiency in supply chain management. Companies are employing more technologies, such as the Internet of Things (IoT), blockchain, and artificial intelligence, to increase visibility and traceability at all stages of the logistics process. These technologies monitor real-time temperature-sensitive pharmaceutical products' temperature levels without allowing violations of the governing standard conditions. It preserves pharmaceutical quality and assists in meeting the regulating standards. Again, they minimise human faults with effective inventory management automation for high operational efficiency. Increasing attention is being paid by the pharmaceutical industry towards sustainable logistics solutions in the second trend. Organisations are trying to reduce carbon footprints where ecological concerns are increasing, and this includes greener practices in their supply chains. This includes optimising transportation routes, use of eco-friendly packaging materials, and application of electric vehicles for last-mile deliveries.Pharmaceutical Logistics Market Leading Players
The key players profiled in the report are Agility, Air Canada, CEVA Logistics, DB Schenker, Deutsche Post AG, FedEx, LifeConEx, Marken, United Parcel Service of America, Inc., VersaCold Logistics ServicesGrowth Accelerators
The increased demand for good supply chain management solutions mainly propels the pharmaceutical logistics market in the healthcare sector. The expansion of the world's pharmaceutical industry requires medicines to be distributed timely, in the right amount, and securely. The growth rates in chronic diseases, as well as an ageing populace and a high incidence of speciality drugs, are all key factors pushing pharmaceutical companies into upscaling their logistics ability. Further stressing the demand are the regulatory requirements for temperature-controlled environments, strict compliance with GDP, and other processes requiring sophisticated logistics solutions that ensure the integrity and safety of pharmaceutical products throughout the supply chain. Another major factor for the pharmaceutical logistics market is the growing trend of e-commerce and direct-to-consumer (DTC) sales in the health sector. As more people are searching for easy ways to access medication, pharmaceutical firms are spending more on solid logistics systems that can accommodate fast and reliable delivery services. The pandemic has accelerated this trend as the importance of robust logistics systems for the distribution of vaccines and other essential medical supplies was underlined.Pharmaceutical Logistics Market Segmentation analysis
The Global Pharmaceutical Logistics is segmented by Type, Application, and Region. By Type, the market is divided into Distributed Cold Chain Logistics, Non-cold Chain Logistics . The Application segment categorizes the market based on its usage such as Bio Pharma, Chemical Pharma, Speciality Pharma. Geographically, the market is assessed across key Regions like {regionNms} and others, each presenting distinct growth opportunities and challenges influenced by the regions.Competitive Landscape
The growth is fuelled by the growing trend of pharmaceuticals, especially temperature-controlled items such as vaccines and biologics, which are supported by complex logistics systems to maintain their effectiveness during transport. The market gives a notable tendency towards cold chain logistics, which is anticipated to register the highest growth due to tough norms governing the market and rising sophistication of pharmaceutical products. Among the companies competing in this market are FedEx Corp., DHL Supply Chain, and Kuehne + Nagel, who are improving their service delivery through modernisation that includes the use of real-time tracking and automation. To enhance their geographical presence and the range of services offered, major players in the pharmaceutical logistics market are increasingly entering into joint ventures and acquisitions. More companies are focusing on building a cold chain infrastructure given the rising appetite for temperature-controlled logistics. Furthermore, the share of the non-cold chain segment is also large given the amount of medicines that do not need temperature control, hence dominating this segment.Challenges In Pharmaceutical Logistics Market
Some of the key challenges the pharmaceutical logistics market faces include regulatory compliance and the complexity of management in the supply chain. Pharmaceutical products have stringent regulations as far as storage, transport, and handling are concerned to ensure that product integrity is maintained and patient safety is guaranteed. Such compliances can be very expensive for companies in terms of infrastructure and training. Not the least, the complexity around cold chain management for items like vaccines and biologics adds to the hassle in logistics operations and provides an added challenge to having assurance of product efficacy when in the manufacturing process to actual points of distribution. Another thing is the increasing demand by logistics providers for faster times and real-time tracking as it relates to shipment visibility. The growth of online purchasing and patient-centric platforms creates pressure on logistics to shorten the shipping time without allowing a decrease in service delivery levels. These will not only involve very specialised technologies such as Internet-of-Things devices, with data analytics in their monitoring shipments and making sure correct routes for deliveries. Most of the integration attempts come at a high price since it is dependent upon more skilled forces along the chain, which leaves behind greater challenges for pharma logistics companies to find and become efficient in managing operations where customer service is also required.Risks & Prospects in Pharmaceutical Logistics Market
The pharmaceutical logistics market holds a lot of promise in the face of increasing demand for efficient and secure supply chain solutions for the rapidly expanding pharmaceutical sector. Biopharmaceutical products, personalised medicine, and cold chain requirements are driving the growth of the pharmaceutical logistics sector, and companies are increasingly looking for advanced logistics solutions to ensure the safe and timely delivery of temperature-sensitive products. It enables logistics service providers to invest in specific transportation and storage facilities equipped with temperature monitoring technology, thereby adhering to stringent regulatory requirements and generally improving supply chain efficiency. E-commerce and online pharmacies have significantly changed the pharmaceutical logistics space, creating new ways through which companies can extend their services. Most consumers are looking for easier access to pharmaceuticals, which is creating demand for last-mile delivery services specific to pharmaceuticals. Such a trend is creating pressure on logistics companies to use innovative technologies, including automation, real-time tracking systems, and data analytics, to make operations efficient and enhance the experience for customers. Such market trends can be capitalised on as an opportunity to become leaders in the fast-changing pharmaceutical logistics space.Key Target Audience
The pharmaceutical logistics market mainly targets pharmaceutical producers, wholesalers, and suppliers who seek means of transport and storage for their products. Such stakeholders are dependent on good logistics services so as to manage temperature-controlled products such as medications, vaccines, and other health products. Due to the strict regulations in place regarding the management and distribution of medicines, such companies look for a logistics company that can provide them with secure, reliable, and, above all, drug logistics-compliant supply chain solutions so as to reduce the loss or spoilage of the drug while in transit.,, Another noteworthy audience of the pharmaceutical logistics market consists of health care service consumers, including hospitals, clinics, and pharmacies, which rely on the regular delivery of specific products. This audience recalls the necessity of the logistics services, which are capable of providing supply chain management as well as a controlled environment for goods and quick turnaround to bring in stocks as per patients’ requests. In addition, the rising tendency of e-commerce in the healthcare sector is also increasing the need for logistics services for online pharmacies and direct patient delivery services, thus providing extra avenues for the logistics business in this ever-changing market.Merger and acquisition
The consolidation of businesses in the pharmaceutical logistics industry has increasingly been witnessed in recent times, and this can be attributed to the desire to improve and expand operational activities. Recent notable deals include the recent acquisition of Olink Holding AB by Thermo Fisher Scientific, which was worth $3.1 billion, and Olink's target Thermo Fisher sectored in next-generation proteomics' solutions. Elsewhere, Eli Lilly has revealed that it will be acquiring Morphic Holding, which develops oral therapies targeting chronic diseases, though no figures were mentioned. These explain why there have been movements in the segments wherein companies are merging in order to become more efficient and to the increasing needs for operators providing logistic services for pharmaceuticals as a result of globalisation and the development of technology. In 2024, the overall M&A activity in the pharmaceutical sector saw a downturn in terms of the number and value of deals when compared with previous periods, and in particular in Q2 when 401 deals worth $34.5 billion were recorded. This retraction is in contrast to the upsurge which M&A had always witnessed in the previous quarters, especially the last one, which indicates that the market is perhaps undergoing adjustment and strategic repositioning as the firms assess the prevailing economic environment. Even so, a large part of the M&A activity was made up of healthcare deals, which suggests that there is still a desire to improve these services even with the crippling costs and regulatory pressures in the pharmaceutical supply chain.- 1.1 Report description
- 1.2 Key market segments
- 1.3 Key benefits to the stakeholders
2: Executive Summary
- 2.1 Pharmaceutical Logistics- Snapshot
- 2.2 Pharmaceutical Logistics- Segment Snapshot
- 2.3 Pharmaceutical Logistics- Competitive Landscape Snapshot
3: Market Overview
- 3.1 Market definition and scope
- 3.2 Key findings
- 3.2.1 Top impacting factors
- 3.2.2 Top investment pockets
- 3.3 Porter’s five forces analysis
- 3.3.1 Low bargaining power of suppliers
- 3.3.2 Low threat of new entrants
- 3.3.3 Low threat of substitutes
- 3.3.4 Low intensity of rivalry
- 3.3.5 Low bargaining power of buyers
- 3.4 Market dynamics
- 3.4.1 Drivers
- 3.4.2 Restraints
- 3.4.3 Opportunities
4: Pharmaceutical Logistics Market by Type
- 4.1 Overview
- 4.1.1 Market size and forecast
- 4.2 Cold Chain Logistics
- 4.2.1 Key market trends, factors driving growth, and opportunities
- 4.2.2 Market size and forecast, by region
- 4.2.3 Market share analysis by country
- 4.3 Non-cold Chain Logistics
- 4.3.1 Key market trends, factors driving growth, and opportunities
- 4.3.2 Market size and forecast, by region
- 4.3.3 Market share analysis by country
5: Pharmaceutical Logistics Market by Application / by End Use
- 5.1 Overview
- 5.1.1 Market size and forecast
- 5.2 Bio Pharma
- 5.2.1 Key market trends, factors driving growth, and opportunities
- 5.2.2 Market size and forecast, by region
- 5.2.3 Market share analysis by country
- 5.3 Chemical Pharma
- 5.3.1 Key market trends, factors driving growth, and opportunities
- 5.3.2 Market size and forecast, by region
- 5.3.3 Market share analysis by country
- 5.4 Speciality Pharma
- 5.4.1 Key market trends, factors driving growth, and opportunities
- 5.4.2 Market size and forecast, by region
- 5.4.3 Market share analysis by country
6: Pharmaceutical Logistics Market by Procedure
- 6.1 Overview
- 6.1.1 Market size and forecast
- 6.2 Retrieval Systems
- 6.2.1 Key market trends, factors driving growth, and opportunities
- 6.2.2 Market size and forecast, by region
- 6.2.3 Market share analysis by country
- 6.3 Handling Systems
- 6.3.1 Key market trends, factors driving growth, and opportunities
- 6.3.2 Market size and forecast, by region
- 6.3.3 Market share analysis by country
- 6.4 Picking
- 6.4.1 Key market trends, factors driving growth, and opportunities
- 6.4.2 Market size and forecast, by region
- 6.4.3 Market share analysis by country
- 6.5 Storage
- 6.5.1 Key market trends, factors driving growth, and opportunities
- 6.5.2 Market size and forecast, by region
- 6.5.3 Market share analysis by country
7: Competitive Landscape
- 7.1 Overview
- 7.2 Key Winning Strategies
- 7.3 Top 10 Players: Product Mapping
- 7.4 Competitive Analysis Dashboard
- 7.5 Market Competition Heatmap
- 7.6 Leading Player Positions, 2022
8: Company Profiles
- 8.1 Agility
- 8.1.1 Company Overview
- 8.1.2 Key Executives
- 8.1.3 Company snapshot
- 8.1.4 Active Business Divisions
- 8.1.5 Product portfolio
- 8.1.6 Business performance
- 8.1.7 Major Strategic Initiatives and Developments
- 8.2 Air Canada
- 8.2.1 Company Overview
- 8.2.2 Key Executives
- 8.2.3 Company snapshot
- 8.2.4 Active Business Divisions
- 8.2.5 Product portfolio
- 8.2.6 Business performance
- 8.2.7 Major Strategic Initiatives and Developments
- 8.3 CEVA Logistics
- 8.3.1 Company Overview
- 8.3.2 Key Executives
- 8.3.3 Company snapshot
- 8.3.4 Active Business Divisions
- 8.3.5 Product portfolio
- 8.3.6 Business performance
- 8.3.7 Major Strategic Initiatives and Developments
- 8.4 DB Schenker
- 8.4.1 Company Overview
- 8.4.2 Key Executives
- 8.4.3 Company snapshot
- 8.4.4 Active Business Divisions
- 8.4.5 Product portfolio
- 8.4.6 Business performance
- 8.4.7 Major Strategic Initiatives and Developments
- 8.5 Deutsche Post AG
- 8.5.1 Company Overview
- 8.5.2 Key Executives
- 8.5.3 Company snapshot
- 8.5.4 Active Business Divisions
- 8.5.5 Product portfolio
- 8.5.6 Business performance
- 8.5.7 Major Strategic Initiatives and Developments
- 8.6 FedEx
- 8.6.1 Company Overview
- 8.6.2 Key Executives
- 8.6.3 Company snapshot
- 8.6.4 Active Business Divisions
- 8.6.5 Product portfolio
- 8.6.6 Business performance
- 8.6.7 Major Strategic Initiatives and Developments
- 8.7 LifeConEx
- 8.7.1 Company Overview
- 8.7.2 Key Executives
- 8.7.3 Company snapshot
- 8.7.4 Active Business Divisions
- 8.7.5 Product portfolio
- 8.7.6 Business performance
- 8.7.7 Major Strategic Initiatives and Developments
- 8.8 Marken
- 8.8.1 Company Overview
- 8.8.2 Key Executives
- 8.8.3 Company snapshot
- 8.8.4 Active Business Divisions
- 8.8.5 Product portfolio
- 8.8.6 Business performance
- 8.8.7 Major Strategic Initiatives and Developments
- 8.9 United Parcel Service of America
- 8.9.1 Company Overview
- 8.9.2 Key Executives
- 8.9.3 Company snapshot
- 8.9.4 Active Business Divisions
- 8.9.5 Product portfolio
- 8.9.6 Business performance
- 8.9.7 Major Strategic Initiatives and Developments
- 8.10 Inc.
- 8.10.1 Company Overview
- 8.10.2 Key Executives
- 8.10.3 Company snapshot
- 8.10.4 Active Business Divisions
- 8.10.5 Product portfolio
- 8.10.6 Business performance
- 8.10.7 Major Strategic Initiatives and Developments
- 8.11 VersaCold Logistics Services
- 8.11.1 Company Overview
- 8.11.2 Key Executives
- 8.11.3 Company snapshot
- 8.11.4 Active Business Divisions
- 8.11.5 Product portfolio
- 8.11.6 Business performance
- 8.11.7 Major Strategic Initiatives and Developments
9: Analyst Perspective and Conclusion
- 9.1 Concluding Recommendations and Analysis
- 9.2 Strategies for Market Potential
Scope of Report
Aspects | Details |
---|---|
By Type |
|
By Application |
|
By Procedure |
|
Report Licenses
Frequently Asked Questions (FAQ):
What is the growth rate of Pharmaceutical Logistics Market?
+
-
What are the latest trends influencing the Pharmaceutical Logistics Market?
+
-
Who are the key players in the Pharmaceutical Logistics Market?
+
-
How is the Pharmaceutical Logistics } industry progressing in scaling its end-use implementations?
+
-
What product types are analyzed in the Pharmaceutical Logistics Market Study?
+
-
What geographic breakdown is available in Global Pharmaceutical Logistics Market Study?
+
-
Which region holds the second position by market share in the Pharmaceutical Logistics market?
+
-
How are the key players in the Pharmaceutical Logistics market targeting growth in the future?
+
-
What are the opportunities for new entrants in the Pharmaceutical Logistics market?
+
-
What are the major challenges faced by the Pharmaceutical Logistics Market?
+
-